[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"pregnancy-early\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:pregnancy-early":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,48,76],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":36,"lastUpdatePostDateStruct":37,"startDateStruct":40,"completionDateStruct":42,"leadSponsor":44,"locationsCount":47},"100556201","ptsd-screening-in-pregnant-black-women-100556201",false,"NCT06522022","PTSD Screening in Pregnant Black Women","Comparing Two Screening Approaches for PTSD to Improve Health Outcomes in Pregnant Black Women","Inclusion Criteria:\n\n* 18+ years old,\n* Ability to provide informed consent,\n* English-speaking,\n* Willingness to participate in the study,\n* Self-identification as Black or African American,\n* Pregnant and in the first trimester attending initial prenatal care visit,\n* Endorsement of at least one traumatic event in their lifetime.\n\nExclusion Criteria:\n\n* Active suicidality",true,"ALL","18 Years",{"count":20,"type":21},804,"ESTIMATED","INTERVENTIONAL",[24],"NA","This study will compare the effectiveness of two active screening interventions in improving post-traumatic stress disorder (PTSD) symptoms, maternal perinatal care utilization, satisfaction utilization of mental healthcare services, and maternal health and birth-related outcomes for Black pregnant women.",[27,28],"Pregnancy Early","PTSD",[30,31,32,33,34],"Pregnancy","Black Women","Screening for Maternal PTSD","Obstetric Care","African-American Women","RECRUITING","2025-10-23",{"date":38,"type":39},"2025-10-27","ACTUAL",{"date":41,"type":39},"2025-02-20",{"date":43,"type":21},"2029-03",{"name":45,"class":46},"Emory University","OTHER",2,{"id":49,"slug":50,"hasResults":11,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":4,"eligibilityCriteria":53,"healthyVolunteers":16,"sex":54,"minAge":4,"maxAge":4,"enrollmentInfo":55,"targetDuration":4,"studyType":22,"phases":57,"briefSummary":58,"conditions":59,"keywords":4,"overallStatus":35,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":75},"100506168","generation-r-next---optimaal-opgroeien-100506168","NCT05870878","Generation R Next - Optimaal Opgroeien","Inclusion Criteria:\n\nWomen and their parents:\n\n* Planning a pregnancy or early pregnancy up to \\\u003C 12 weeks\n* With the presence of at least one of the predetermined risk factors\n* Residential address in the municipality of Rotterdam and expected residential address in the municipality of Rotterdam at the birth of their child\n* Consent for participation\n\nExclusion Criteria:\n\nWomen and their partners:\n\n* Temporary or complete withdrawal from participation\n* Gestational age \\> 12+0 at study entry","FEMALE",{"count":56,"type":21},1750,[24],"The aim of this randomized controlled trial is to improve birth outcomes and long-term outcomes in mother and child by optimizing lifestyle,nutrition and stress experience in the preconception period and early pregnancy in women and men\n\nThe main research question that will be addressed is: Does an intervention focused on optimizing preconception and early pregnancy lifestyle, nutrition and stress improve the birth outcomes and long-term outcomes in mother and child?\n\nParticipants will receive an individual lifestyle consultation at the start of the study. Depending on their study arm, participants will receive an additional lifestyle program focused on health during preconception and early pregnancy, coping with stress and adherence to a healthy(er) lifestyle. The given advices are based on national guidelines.\n\nResearchers will compare the intervention group and control group to see if (adherence to) this lifestyle program improve birth outcomes and long-term outcomes in mother and child.",[27,60,61,62,63,64,65],"Outcome, Adverse Birth","Lifestyle Factors","Preconception Care","Pregnancy Outcome","Pregnancy Complications","Risk Reduction Behavior","2024-08-30",{"date":68,"type":39},"2024-09-04",{"date":70,"type":39},"2023-01-19",{"date":72,"type":21},"2030-11-08",{"name":74,"class":46},"Erasmus Medical Center",1,{"id":77,"slug":78,"hasResults":11,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":4,"eligibilityCriteria":82,"healthyVolunteers":16,"sex":54,"minAge":18,"maxAge":83,"enrollmentInfo":84,"targetDuration":4,"studyType":22,"phases":86,"briefSummary":89,"conditions":90,"keywords":4,"overallStatus":92,"whyStopped":4,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":4},"100553961","phase-2-assessing-the-efficacy-and-acceptability-of-two-missed-period-pills-regimens-100553961","NCT06492889","Assessing the Efficacy and Acceptability of Two Missed Period Pills Regimens","Randomized Trial Comparing Progestin With Mifepristone Versus Mifepristone Alone for Use as Missed Period Pills","Inclusion Criteria:\n\n* Age 15-49 years\n* General good health\n* Does not want to be pregnant\n* History of regular monthly menstrual cycles (+\u002F- 3 days)\n* Missed menses of 2 to 8 days\n* Sexual activity in the past month\n* Willing and able to sign consent forms\n* Willing to return for a follow-up visit\n* Willing to provide urine sample at enrollment and follow-up\n\nExclusion Criteria:\n\n* Known allergies or contraindications to either study drug\n* Symptoms or risk factors for ectopic pregnancy\n* Current use of an IUD, contraceptive implant or injectable","49 Years",{"count":85,"type":21},286,[87,88],"PHASE2","PHASE3","The goal of this trial is to examine the efficacy and acceptability of two medication regimens at inducing a return of menses when used 2-8 days after a missed period. The first regimen consists of one dose of 1.5 mg levonorgestrel followed one to two days later by one dose of 200 mg mifepristone. The second regimen will consist of one dose of a placebo pill, followed one to two days later by one dose of 200 mg mifepristone.\n\nThe investigators will assess and compare the efficacy of both regimens (proportion of women in each group not pregnant at follow-up who were determined to be pregnant at enrollment), and the effectiveness of both regimens (proportion of all participants not pregnant at follow-up among all participants enrolled)",[27,91],"Pregnancy Related","NOT_YET_RECRUITING","2024-07-17",{"date":95,"type":39},"2024-07-18",{"date":97,"type":21},"2024-07-22",{"date":99,"type":21},"2025-06-30",{"name":101,"class":46},"Gynuity Health Projects"]